Skip to content

Non Pharmacological Management of Behavioural Symptoms in Nursing Home

Not Pharmacologic Treatment Has Illness of Alzheimer and Pathologies Related. Application in Disturbances of Behaviour in EHPAD

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00824967
Enrollment
306
Registered
2009-01-19
Start date
2007-10-31
Completion date
2009-10-31
Last updated
2012-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ALZHEIMER Disease

Brief summary

Background: Behavioural and psychological symptoms of dementia (BPSD) are often reported in institutions for the elderly. Objective: To evaluate the effectiveness of a staff education intervention to manage BPSD in older people with a diagnosis of dementia.

Detailed description

Background: Behavioural and psychological symptoms of dementia (BPSD) are often reported in institutions for the elderly. Objective: To evaluate the effectiveness of a staff education intervention to manage BPSD in older people with a diagnosis of dementia. Methods: The trial was conducted in 16 nursing homes; 306 patients with a diagnosis of dementia and presenting BPSD were selected. Nursing homes were randomly allocated to an intervention group or a control group. An eight-week staff education and training programme was conducted in the nursing homes in the intervention group. The main outcome measures were the Cohen-Mansfield Agitation Inventory (CMAI) and an observation scale score. Assessments were done at baseline (W0), at the end of the 'intervention' period (W8) and 12 weeks after (W20).

Interventions

OTHERTraining and valuation of the treating personnel

Training and valuation of the treating personnel

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Alzheimer disease

Exclusion criteria

* Not alzheimer disease

Design outcomes

Primary

MeasureTime frame
Changes at the behavioural assessment (CMAI, OS, NPI) after 8 weeks of intervention8 weeks after intervention

Secondary

MeasureTime frame
Changes at the behavioural assessment (CMAI, OS, NPI) 16 weeks after the end of the intervention16 weeks after intervention

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026